Michael Yee (Allogene open house Credit: Jeff Rumans)

Hold the phone, bio­phar­ma: FDA-im­posed clin­i­cal holds are on the rise

Are clin­i­cal holds on the rise? Ac­cord­ing to one analy­sis, signs point to yes, and one field, in par­tic­u­lar, is prov­ing a like­ly cul­prit. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.